Asthma pharmacological treatment
Pro Research Analysisby 
Searched over 200M research papers
Stepwise Approach to Asthma Pharmacological Treatment
Asthma pharmacological treatment is generally based on a stepwise approach, where therapy is adjusted according to the severity of the disease. The main goals are to reduce symptoms, prevent exacerbations, and maintain normal lung function. Inhaled corticosteroids (ICS) are the foundation of long-term asthma control, with the dose and additional medications tailored to the patient's needs and response to treatment 167.
Key Drug Classes in Asthma Management
Inhaled Corticosteroids and β2-Adrenoceptor Agonists
ICS are the most effective anti-inflammatory drugs for asthma and are recommended at all steps of persistent asthma management. Short-acting β2-agonists (SABA), such as salbutamol, are used for quick relief of acute symptoms, while long-acting β2-agonists (LABA) are added for patients whose asthma is not controlled with ICS alone. The combination of ICS and LABA in a single inhaler is considered the gold standard for moderate to severe asthma, offering improved efficacy and a potential steroid-sparing effect 1456+2 MORE.
Add-On and Alternative Therapies
For patients who do not achieve control with ICS and LABA, additional options include leukotriene receptor antagonists (LTRA), long-acting muscarinic antagonists (LAMA), sustained-release theophylline, and, in severe cases, oral corticosteroids. These add-on therapies are chosen based on individual patient characteristics and response to treatment 1456+1 MORE.
Biologic Therapies for Severe Asthma
In patients with severe, uncontrolled asthma—especially those with Type 2-high endotypes characterized by eosinophilic inflammation—biologic therapies have become important. Monoclonal antibodies targeting IgE (omalizumab), IL-5 and its receptor (mepolizumab, benralizumab, reslizumab), and IL-4/IL-13 pathways (dupilumab) have shown effectiveness in reducing exacerbations and improving lung function in this subgroup 36. Tezepelumab, targeting thymic stromal lymphopoietin, is a newer option for severe asthma .
Mechanisms and Targets in Asthma Pharmacotherapy
Many asthma drugs act on G protein–coupled receptors (GPCRs) to either promote bronchodilation or prevent bronchoconstriction. β2-agonists activate β2-adrenergic receptors for bronchodilation, while muscarinic antagonists block acetylcholine-induced bronchoconstriction. LTRAs block leukotriene receptors to reduce inflammation and bronchoconstriction. New drugs targeting other GPCRs and inflammatory mediators are under development, aiming to address unmet needs in asthma care 4510.
Cost-Effectiveness and Practical Considerations
ICS are generally more cost-effective than LTRA for persistent asthma. Adding LABA to ICS is also cost-effective, especially when using combination inhalers for both maintenance and relief. Biologics like omalizumab may be cost-effective in selected patients with severe asthma, but their use is limited by high costs and is reserved for those with the most severe disease . Treatment choices can also be influenced by patient convenience, side effects, and healthcare system factors such as reimbursement policies 12.
Guidelines and Special Considerations
National and international guidelines recommend a stepwise approach, regular assessment, and adjustment of therapy. Management should also address comorbidities such as allergic rhinitis and chronic rhinosinusitis, and consider special situations like pregnancy or aspirin-exacerbated respiratory disease 67.
Conclusion
Asthma pharmacological treatment relies on a stepwise approach, starting with inhaled corticosteroids and adding other agents as needed. Combination inhalers with ICS and LABA are the mainstay for most patients, while biologic therapies are reserved for severe, uncontrolled cases. Ongoing research is focused on developing new therapies targeting specific inflammatory pathways, but current treatments remain effective for the majority of patients when used appropriately 1345+3 MORE.
Sources and full results
Most relevant research papers on this topic